Bioxytran, Inc. (BIXT)
OTCMKTS · Delayed Price · Currency is USD
0.0684
+0.0001 (0.15%)
Nov 5, 2025, 10:24 AM EST
Bioxytran Market Cap
Bioxytran has a market cap or net worth of $6.08 million as of November 5, 2025. Its market cap has decreased by -32.81% in one year.
Market Cap
6.08M
Enterprise Value
7.46M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.07
Market Cap Chart
Since September 24, 2018, Bioxytran's market cap has decreased from 25.52M to 6.08M, a decrease of -76.18%. That is a compound annual growth rate of -18.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 6.08M | -22.09% |
| Dec 31, 2024 | 7.80M | -64.29% |
| Dec 29, 2023 | 21.85M | -63.00% |
| Dec 30, 2022 | 59.05M | 33.18% |
| Dec 31, 2021 | 44.34M | 89.57% |
| Dec 30, 2020 | 23.39M | -4.77% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 24, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 666.34M |
| Glass House Brands | 582.61M |
| Northwest Biotherapeutics | 386.96M |
| Nika Pharmaceuticals | 311.89M |
| CytoDyn | 311.61M |
| Silence Therapeutics | 307.49M |
| American Oncology Network | 305.39M |